Cetus into interleukin-2 race
Executive Summary
Firm received IND clearance from FDA to begin clinicals on AIDS patients. Studies of the rDNA produced immune-stimulant will be conducted at San Francisco General Hospital. Similar trials at NIH were recently started using interleukin-2 produced by Collaborative Research and Roche/Immunex.